Recent Finacing
Recent Raise
Auspex Pharmaceuticals is a clinical-stage biotech that applies deuterium substitution to drugs, developing SD-809 (a deuterated VMAT2 inhibitor) for hyperkinetic movement disorders and programs in JAK and fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
